Language

News topic

ATC group N01BB09

Current shortage notices for the ATC group N01BB09, structured by product, country and reporting period.

22 notices

← All shortages

What the N01BB09 notices indicate for the supply chain

The 22 consolidated notices from Austria, Belgium, Germany are market and supply signals. They do not confirm current Inter-Pharma stock or a general ability to supply. Operational assessment requires separate verification of product status, batch, expiry, temperature requirements, recipient authorisation and the permitted distribution route.

GDP-capable pharmaceutical storage in Cheb

Inter-Pharma supports manufacturers, wholesalers and logistics partners with GDP-capable pharmaceutical storage in Czechia. Its own Cheb site enables project-specific buffer and safety stocks, batch and expiry control, FEFO, stock-status management, picking and dispatch preparation for Germany and Europe.

Austria

Ropivacain-HCl B. Braun 7,5 mg/ml Injektionslösung

Active ingredient: ROPIVACAIN HYDROCHLORID

View notice details →
Belgium

Naropin 5 mg/ml inj. sol. i.thec. amp. 5 x 10 ml

Active ingredient: Ropivacaine Hydrochloride

View notice details →
Austria

Ropivacain-HCl B. Braun 2 mg/ml Injektions-/ Infusionslösung

Active ingredient: ROPIVACAIN HYDROCHLORID

View notice details →
Belgium

Ropivacaine Fresenius Kabi 7.5 mg/ml inj. sol. epidur. amp. 5 x 20 ml

Active ingredient: Ropivacaine Hydrochloride

View notice details →
Belgium

Ropivacaine Fresenius Kabi 2 mg/ml inf. sol. epidur. 5 x 100 ml

Active ingredient: Ropivacaine Hydrochloride

View notice details →
Belgium

Naropin 2 mg/ml inj. sol. epidur. amp. 5 x 20 ml

Active ingredient: Ropivacaine Hydrochloride

View notice details →
Belgium

Ropivacaine Fresenius Kabi 5 mg/ml inj. sol. i.thec. amp. 5 x 10 ml

Active ingredient: Ropivacaine Hydrochloride

View notice details →
Germany

Ropivacain HCl B. Braun 2 mg/ml Injektions-/Infusionslösung

Active ingredient: Ropivacainhydrochlorid-Monohydrat

View notice details →
Germany

Ropivacainhydrochlorid Kabi 2 mg/ml Infusionslösung

Active ingredient: Ropivacainhydrochlorid

View notice details →
Belgium

Naropin 7.5 mg/ml inj. sol. epidur. amp. 5 x 20 ml

Active ingredient: Ropivacaine Hydrochloride

View notice details →
Germany

Ropivacainhydrochlorid Kabi 7,5 mg/ml Injektionslösung

Active ingredient: Ropivacainhydrochlorid

View notice details →
Austria

Ropivacainhydrochlorid Kabi 5 mg/ml Injektionslösung

Active ingredient: ROPIVACAINHYDROCHLORID MONOHYDRAT

View notice details →
Germany

Ropivacainhydrochlorid Kabi 2 mg/ml Injektionslösung

Active ingredient: Ropivacainhydrochlorid

View notice details →
Belgium

Ropivacaine Fresenius Kabi 2 mg/ml inf. sol. epidur. 5 x 100 ml

Active ingredient: Ropivacaine Hydrochloride

View notice details →
Belgium

Naropin 7.5 mg/ml inj. sol. epidur. amp. 5 x 20 ml

Active ingredient: Ropivacaine Hydrochloride

View notice details →
Belgium

Ropivacaine Fresenius Kabi 10 mg/ml inj. opl. epidur. amp. 5 x 20 ml

Active ingredient: Ropivacaine Hydrochloride

View notice details →
Belgium

Ropivacaine Fresenius Kabi 7.5 mg/ml inj. opl. epidur. amp. 5 x 20 ml

Active ingredient: Ropivacaine Hydrochloride

View notice details →
Belgium

Ropivacaine Fresenius Kabi 2 mg/ml inf. opl. epidur. 5 x 100 ml

Active ingredient: Ropivacaine Hydrochloride

View notice details →
Germany

Ropivacainhydrochlorid Kabi 2 mg/ml Injektionslösung

Active ingredient: Ropivacainhydrochlorid

View notice details →
Belgium

Ropivacaine Fresenius Kabi 2 mg/ml inj. opl. epidur. amp. 5 x 20 ml

Active ingredient: Ropivacaine Hydrochloride

View notice details →
Belgium

Ropivacaine Fresenius Kabi 2 mg/ml inf. opl. epidur. 5 x 200 ml

Active ingredient: Ropivacaine Hydrochloride

View notice details →
Germany

Ropivacainhydrochlorid Kabi 10 mg/ml Injektionslösung

Active ingredient: Ropivacainhydrochlorid

View notice details →

Plan supply. Connect sourcing and warehousing.

For pharmacies, wholesalers and manufacturers: choose the service matching your operational need.